Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
Back
Product details:
CAS
112522-64-2
Purity
95%
Tacedinaline is a selective class I HDAC inhibitor. Tacedinaline has been used in trials studying the treatment of lung cancer, multiple myeloma, and pancreatic cancer.
Properties
Name
Tacedinaline
Smiles
CC(=O)NC=1C=CC(=CC1)C(=O)NC=2C=CC=CC2N
Targets
Please log in to see this information
SDS
4-(acetylamino)-N-(2-aminophenyl)benzamide | 4-acetamido-N-(2-aminophenyl)benzamide | CI-994 | Cl-994 | N-acetyldinaline | Tacedinaline
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$45
2 mg
$47
5 mg
$48
10 mg
$49
15 mg
$50
20 mg
$51
25 mg
$55
30 mg
$57
35 mg
$65
40 mg
$72
45 mg
$79
50 mg
$86
75 mg
$92
100 mg
$94
Quantity
1
Total amount
$ 48
4-(acetylamino)-N-(2-aminophenyl)benzamide | 4-acetamido-N-(2-aminophenyl)benzamide | CI-994 | Cl-994 | N-acetyldinaline | Tacedinaline
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.
CAS:1299346-14-7
0